GlassScriptPhysician profile
Paul Adenuga
NPI 1740675057
$9,423.97
in general payments reported to CMS, 2019-2025
20 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $141 · 2021: $710 · 2022: $781 · 2023: $5,278 · 2024: $1,916 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,026 · Food and Beverage: $3,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,026.15 |
| Food and Beverage | $3,462.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,440.09 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Abbvie INC. | $2,224.59 | 2023 | Natrelle Saline-Filled Breast Implants, Revolve, Alloderm |
| Allergan, INC. | $1,071.12 | 2021-2022 | |
| Arthrex, INC. | $997.24 | 2024 | |
| Kerecis Limited | $857.42 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $426.29 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $315.73 | 2019-2025 | Phasix Mesh |
| Checkpoint Surgical, INC | $202.20 | 2025 | Checkpoint Stimulators |
| Sientra, INC. | $155.97 | 2021 | |
| Mentor Worldwide LLC | $148.70 | 2023 | Artoura Breast Tissue Expander |
| Acell, INC. | $140.88 | 2020 | |
| Skeletal Dynamics INC | $133.50 | 2024 | Align, Implate, Geminus |
| Endo USA, INC. | $120.53 | 2024 | Xiaflex |
| Convatec INC. | $61.64 | 2023 | |
| Smith+Nephew, INC. | $32.48 | 2024 | Stravix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $28.86 | 2024 | |
| Stryker Corporation | $25.00 | 2024 | Variax |
| Portola Pharmaceuticals, LLC | $20.13 | 2019 | |
| Globus Medical, INC. | $15.74 | 2023 | Mini Fragment System |
| Musculoskeletal Transplant Foundation INC. | $5.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Adenuga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.